Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy.

Front Endocrinol (Lausanne) · 2023 · PMC10807287 · PMID 38269251

Europe PMC DOI

hedged sentence

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

a statistical trendp = 0.089so close (0.05 < p ≤ 0.1)

In addition, out of the five patients who showed overt hypogonadism at T3, and therefore started T gel-treatment, two switched to compensated hypogonadism at T4, with a statistical trend (p = 0.089) toward the reduction of overt hypogonadism frequency ( Figure 2B ).

also in 1,033 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.